CTX-471

• CAT Number: I043207
• CAS Number: 2377152-49-1
• Molecular Formula: CT
• Purity: ≥95%

CTX-471（Cat No.:I043207）is an investigational immunotherapy currently being studied for its potential use in cancer treatment. It is a selective agonist of the CD40 receptor, which plays a critical role in activating the immune system. By stimulating CD40 on dendritic cells and other immune cells, CTX-471 enhances immune responses against tumors, potentially improving the effectiveness of cancer immunotherapy. It is being evaluated in clinical trials for its ability to activate both innate and adaptive immune systems, with the goal of improving outcomes in various cancers, including solid tumors and hematologic malignancies.